Dr Marc Bollet, radiation oncologist at Hartmann, Paris France is a specialist involved in modern cancer treatments such as stereotactic radiotherapy. Since May 2011, Dr. Marc Bollet, whose father is French and mother is British, has been a clinical radiation oncologist at the Institut de Cancérologie Hartmann, relocated in August 2012 onto the site of the Franco-British Hospital.
During his medical studies at Nancy University his deep interest in science led him to obtaining additional University degrees: M.Sc.in Biological and Medical Sciences, M.Sc. in Biochemistry followed by the Inter-University Diploma CESAM (Certificat d’Etudes Statistiques Appliquées à la Médecine), Statistics Applied to Medicine. He was then awarded a State Scholarship that financed a year of research into Radiation and Imagery in Medicine, thus obtaining a DEA (Diplôme d’Etudes Approfondies) at the University of Toulouse in 1998.The scholarship also enabled him to do research into the improvement of the reproducibility of the radiotherapy of pelvic cancers such as prostate cancer.
The subject of his M.D. thesis in 2000 was ‘The Stereotactic Radiotherapy’, a sophisticated technique that is becoming more and more widely used.
Seven years later, in 2007, the subject of his Ph.D. thesis, at Paris-Sud University, was ‘The clinical and histological study and genetic profile examination of the local relapse of breast cancer, after conservative treatment, in the young patient’.
In 2009, having continued his research during a post-doc year at the Netherlands Cancer Institute at Amsterdam, and having supervised three graduate theses, he was awarded the HDR (Habilitation à Diriger des Recherches – the Capacity to Supervise Research) by the Paris Descartes University. In total, he has published to date, 86 articles in peer reviewed international journals and has given many oral presentations at the invitation of scientific and learned societies.
Dr. Bollet has had professional experience as a cancer specialist in several French Oncology Centres: Anti – Cancer Centres, University Teaching Hospitals, locum periods in Private Clinics in Lorraine, the Nord, Champagne and Paris regions and has therefore been given the opportunity to build up friendships and collaborations with numerous actors in the field of French oncology. These contacts led to the development within the PHRC 2006 (Programme Hospitalier de Recherches Cliniques – Hospital Programme for Clinical Research) of an across board hospital programme for clinical research.
On an international level, Dr. Bollet has had the privilege of gaining considerable professional medical and scientific experience in such prestigious oncology centres as: the Royal Marsden Hospital, London, U.K. in 2000, where he held a fellowship post for one year ; the NKI Amsterdam, where he spent a post – doc year.
From 2003 to 2011, he was a specialist oncologist at the Institut Curie, Paris. This variety of professional experiences has meant that he has been able to build up very numerous friendships and professional contacts, both at home and abroad.
Dr. Bollet’s deep interest in the teaching and transmitting of medical knowledge led him, very early on, to training young medical students, preparing them for their internship competitive examinations. When he was Chef de Clinique – Senior Lecturer – at the Nancy University Teaching Hospital, he introduced the Anglo-Saxon tutorial method that he had experienced at the Royal Marsden Hospital, London, based on bibliographical sessions (Journal Club) and the resolution of clinical cases. This method is the inspiration that led to the setting up, in 2006, of the CORP (Club des Oncologues Radiothérapeutes de Paris – the Paris Oncologists and Radiotherapists Club) with his friends, Dr. Alain Toledano, Dr. Hanah Lamallem and Dr. Laurent Quero. For the first five years he was its deputy chairman and since November 2011, has been the chairman. He also fulfills his teaching vocation at the ESTRO (European Society for Therapeutic Radiation Oncology) as well as in Morocco and Tunisia at the invitation of their learned societies.
Another of his deep interests is the bringing together of and facilitating contacts between clinicians and non-medical scientists; to that end he regularly organizes congresses and symposiums. In 2008 he chaired the scientific and medical sessions at the Institut Curie, Paris.
Numerous learned societies such as the SFRO (Société Française de Radiothérapie Oncologique), the ANSM ex Afssaps (Agence Nationale de Sécurité du Médicament et des produits de Santé -the French Drugs Agency), French and International Pharmaceutical Laboratories (Novartis, Sanofi-Aventis, Roche …), regularly consult him for expert advice.
His activities as editor in chief of the on-line France Cancer Journal (www.france-cancer.net), as a member of the editorial staff of the Gynecology On-Line Journal (www.gyneco-online.com) and the Lettre du Sénologue – Senologist’s Letter (www.senologie.edimark.fr/publications/LES), as proof reader and peer reviewer for well-known cancerology journals such as the International Journal of Radiation Oncology, Biology and Physics, Radiation Oncology, Journal of Pathology, mean that Dr.Bollet continues to be greatly involved in the diffusion of scientific knowledge within the medical community.
In 2014, Dr. Bollet began his clinical activity at the American Hospital of Paris becoming the new head of the Oncology Department until he passed on the baton to his friend and associate Professor Lionel Vedrine in February 2016. His motivation: homogenising the various practices in the treatment of cancer and providing high quality care that combines cutting-edge techniques with humanity. With his partners, he is developing recourse to the biological characterization of tumours in order to increase personalised therapeutic solutions, with particular attention to the field of clinical research (http://www.unicancer/programme-acse ).
In total, he has published to date, 86 articles in peer reviewed international journals, including:
- Bollet MA, Belin L, Reyal F, Campana F, Dendale R, Kirova YM, Thibault F, Diéras V, Sigal-Zafrani B, Fourquet A.
Preoperative radio-chemotherapy in early breast cancer patients: long-term results of a phase II trial.
Radiother Oncol.2012 Jan;102(1):82-8
- Bollet MA, Servant N, Neuvial P, Decraene C, Lebigot I, Meyniel JP, De Rycke Y, Savignoni A, Rigaill G, Hupe P et al:
High-Resolution Mapping of DNA Breakpoints to Define True Recurrences Among Ipsilateral Breast Cancers.
J Natl Cancer Inst 2008, 100(1):48-58.
- Bollet MA, Anxionnat R, Buchheit I, Bey P, Cordebar A, Jay N, Desandes E, Marchal C, Lapeyre M, Aletti P et al: Efficacy and morbidity of arc-therapy radiosurgery for cerebral arteriovenous malformations: a comparison with the natural history. Int J Radiat Oncol Biol Phys 2004, 58(5):1353-1363.
- Bollet MA, McNair HA, Hansen VN, Norman A, O’Doherty U, Taylor H, Rose M, Mukherjee R, Huddart R: Can digitally reconstructed radiographs (DRRS) replace simulation films in prostate cancer conformal radiotherapy? Int J Radiat Oncol Biol Phys 2003, 57(4):1122-1130.
- Bollet MA, Lapeyre M, Marchal C, Hoffstetter S, Peiffert D, Cornes PG, Luporsi E, Bey P: Cervical lymph node relapses of head-and-neck squamous cell carcinoma: is brachytherapy a therapeutic option? Int J Radiat Oncol Biol Phys 2001, 51(5):1305-1312.
More Publications on PubMed.gov
- HDR, Paris-Descartes University 2009
- Thèse de Science (Ph.D.), Paris Sud University 2007
- Diplôme d’Etudes Spécialisées Complémentaires en Cancérologie 2003
- Diplôme d’Etudes Spécialisées en Oncologie option Radiothérapie 2001
- Diplôme d’Etat de Docteur en Médecine (M.D.) 2000
- Diplôme d’Etudes Approfondies: Rayonnements et imagerie en médecine 1999
- Diplôme Inter-Universitaire de Statistique (C.E.S.A.M) 1997
- Internat national (Spécialité choisie : Oncologie option Radiothérapie) 1995
- Diplôme de Maîtrise de Sciences Biologiques et Médicales section libre 1992
- Concours du premier cycle des études médicales 1990
- Baccalauréat scientifique (Maths & Physiques) 1989